-transparent.png){kind=logo}
The Fas ligand (FasL), a member of the tumor necrosis factor family, induces apoptosis in Fas-expressing cells. A matrix metalloproteinase-like enzyme cleaves the membrane-bound FasL to produce the soluble FasL (sFasL). Since FasL has been reported to play a pivotal role in the development of hepatitis, we evaluated clinical significance of serum sFasL in acute liver injury including acute self-limited and fulminant hepatitis. Serum sFasL in 19 patients including 12 with acute self-limited hepatitis and 7 with fulminant hepatitis was measured by an enzyme-linked immunosorbent assay (ELISA). The clinical data consisted of 18 indices including age, sex, liver function tests, hepatocyte growth factor (HGF), outcome and sFasL. Serum sFasL in fulminant hepatitis is 0.06+/-0.01 ng/ml, being identical to that in acute self-limited hepatitis, Serum sFasL is positively correlated with AST and ALT (p<0.0001 and p<0.0001). The factors associated with outcome of the patients were HGF, albumin, prothrombin time, platelet count, cholinesterase and leukocyte count in this order. Serum sFasL serves as an indicator of liver injury in acute self-limited and fulminant hepatitis.
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
January 2008,
Immunological investigations,
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
December 2006,
The Korean journal of hepatology,
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
July 2001,
Cancer,
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
September 2011,
American journal of reproductive immunology (New York, N.Y. : 1989),
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
June 2001,
Journal of critical care,
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
June 2004,
Journal of medical virology,
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
June 1999,
Coronary artery disease,
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
February 2006,
Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases,
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
October 2002,
Cancer biotherapy & radiopharmaceuticals,
G Shiota, and
K Oyama, and
N Noguchi, and
Y Takano, and
S Kitaoka, and
H Kawasaki
December 1999,
Clinical and experimental immunology,
